脾酪氨酸激酶,spleen tyrosine kinase
1)spleen tyrosine kinase脾酪氨酸激酶
1.Expression of Syk protein in ovarian carcer and its clinical significanceObjective To explore the expressions and their clinical significance of spleen tyrosine kinase(Syk) protein in human ovarian carcer.目的检测脾酪氨酸激酶(Spleen tyrosine kinase,Syk)在卵巢良、恶性组织中的表达,分析其与卵巢癌临床病理参数之间的关系,探讨其临床意义。
2.OBJECTIVE: To explore the expression and its clinical significance of Syk(spleen tyrosine kinase) gene in cervical carcinoma.目的:探讨脾酪氨酸激酶(spleentyrosine kinase,Syk)在宫颈癌组织的表达及其临床意义。
英文短句/例句

1.DNA Promoter Methylation in the Effect of Spleen Tyrosine Kinase (Syk) Gene Expression in the Lung CancerDNA启动子甲基化在脾酪氨酸激酶Syk肺癌表达中的影响
2.Preliminary Research of RAI16 Protein Interacting with Tec Tyrosine Kinase;Tec酪氨酸激酶作用蛋白RAI16的初步研究
3.Expression of receptor tyrosine kinase EphA1 in gastric cancer and its clinicopathological significance受体酪氨酸激酶EphA1 mRNA在胃癌中的表达
4.The name is soluble f-m-s-like tyrosine kinase one?这种蛋白质叫做可溶解fms样酪氨酸激酶一,
5.The Research of Antibody Against Muscle-specific Tyrosine Kinase in Myasthenia Gravis among Chinese;重症肌无力患者酪氨酸激酶抗体的相关研究
6.Tec Tyrosine Protein Kinase Involved in Multidrug Resistance of Hepatocelluar Carcinoma;Tec酪氨酸蛋白激酶参与肝癌多药耐药的研究
7.c-Abl Stabilizes Estrogen Receptor by Phosphorylation and Regulates Its Transcription Activity;c-Abl非受体酪氨酸激酶调节ERα转录活性的研究
8.Study on the Prevalence of Protein Tyrosine Kinase JAK2V617F Mutation in the Western Population;西方人群中蛋白质酪氨酸激酶JAK2~(V617F)突变率研究
9.Expression and Clinical Significance of Receptor Tyrosine Kinase RON in Lung Carcinoma肺癌组织中酪氨酸激酶受体RON的表达及意义
10.Molecular targeted therapies:targeting receptor tyrosine kinases in the treatment of gastric cancer靶向于受体酪氨酸激酶的胃癌分子靶向治疗
11.Tyrosine Kinase Mutation and Acute Myeloid Leukemia with t(8;21)酪氨酸激酶突变与t(8;2急性髓系白血病
12.Advances in the inhibitors of FLT-3 receptor tyrosine kinaseFLT-3受体酪氨酸激酶抑制剂的研究进展
13.Multi-targeted protein tyrosine kinase inhibitor:research advances多靶点蛋白酪氨酸激酶抑制剂的研究进展
14.Advances in the research of multi-target tyrosine kinase inhibitors多靶点抗肿瘤酪氨酸激酶抑制剂的研究开发
15.Expression of receptor tyrosine kinase EphA7 in gastric carcinoma and its clinical significances受体酪氨酸激酶EphA7基因在胃癌中的表达及意义
16.Effect of Receptor Protein-tyrosine Kinases in Tumor Angiogenesis受体酪氨酸激酶在肿瘤血管新生中的作用
17.Progress in research of multi-targeted inhibitors of receptor tyrosine kinase多靶点受体酪氨酸激酶抑制剂的研究进展
18.The Effects of Src Family Kinases on Na, K-ATPase in Formation of Cortex Cataract in VitroSrc-家族酪氨酸激酶在皮质性白内障中对Na,K-ATP酶的影响
相关短句/例句

Syk脾酪氨酸激酶
1.The expression of Syk and VEGF-C proteins were assayed by immunohistochemical staining.方法收集40例胰腺癌、9例慢性胰腺炎、8例正常胰腺组织标本,应用免疫组织化学方法和RT-PCR检测脾酪氨酸激酶(Syk)和血管内皮生长因子-C(VEGF-C)表达情况,分析两者表达与胰腺癌临床病理特征的相关性。
3)Spleen tyrosine kinase脾脏酪氨酸激酶
4)SYKmRNA脾酪氨酸激酶SYK
5)Syk(L)长脾脏酪氨酸激酶
6)Syk (Spleen Tyrosine (Y) Kinase) gastric carcinoma脾酪氨酸蛋白激酶
延伸阅读

酪氨酸蛋白激酶抑制剂分子式:CAS号:性质:一类能抑制蛋白质酪氨酸激酶活性的化合物。酪氨酸蛋白激酶能特异性地将磷酸根转移到蛋白质的酪氨酸残基上使其磷酸化,是许多配体活化的生长因子受体和一些癌基因产物,在肿瘤组织中含量高。酪氨酸蛋白激酶抑制剂可作为ATP与酪氨酸蛋白激酶结合的竞争性抑制剂,也可作为酪氨酸的类似物阻断表皮生长因子受体的肽位点和酪氨酸蛋白激酶的编码,抑制细胞增殖,可望开发为抗肿瘤药物,但对完整细胞没有表现出选择性。